Drug and pharmaceutical recalls
346 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
Recent recalls
Page 11 of 12- Check your Aquarion Preserved Cartridges lot number
Encon Safety Products is recalling specific lots of AQ 120 GFEW Aquarion Preserved Cartridges due to manufacturing process deviations that do not meet FDA standards. The cartridges were distributed nationwide. No injuries have been reported.
ModerateFDAJan 21, 2026Encon Safety Products
- Check your Alvogen Thyro-Tabs levothyroxine bottle
One bottle of Alvogen Thyro-Tabs 150mcg levothyroxine tablets (Lot MHA21825) was found to contain 88mcg tablets instead of the labeled 150mcg strength. This mix-up affects only a single bottle distributed nationwide. No injuries have been reported.
ModerateFDAJan 21, 2026Alvogen
- Stop using TESTO-100 testosterone pellets
Advanced Pharmaceutical Technology is recalling TESTO-100 CIII testosterone pellets (Lot P-22-3, expiration 06-2027) because they may not be sterile and could be contaminated with harmful microbes. These are prescription implant pellets used for testosterone replacement therapy. The recall affects 22,843 pellets distributed in Georgia, New York, Texas, Puerto Rico, the United Kingdom, Malta, and Greece.
ModerateFDAJan 21, 2026Advanced Pharmaceutical Technology
- Stop using Sun Pharmaceutical clindamycin solution
Sun Pharmaceutical has recalled three lots of clindamycin phosphate 1% topical solution due to failed quality tests. The affected batches contain higher-than-acceptable impurities and may not contain the correct amount of active ingredient, which could reduce effectiveness.
ModerateFDAJan 21, 2026Sun Pharmaceutical
- Sun Pharmaceutical fluocinolone solution recalled for impurity failure
Taro Pharmaceuticals is recalling specific lots of fluocinolone acetonide topical solution (0.01%) because testing found higher-than-allowed levels of an impurity. The affected lots were distributed nationwide. No injuries have been reported.
ModerateFDAJan 21, 2026Sun Pharmaceutical
- Stop using AvKARE Rosuvastatin 10 mg tablets
AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.
ModerateFDAJan 14, 2026AvKARE
- MediNatura ReBoost and ClearLife nasal sprays recalled for contamination
MediNatura is recalling two nasal sprays: ReBoost Nasal Spray and ClearLife Allergy Nasal Spray, Extra Strength, both in 20 mL bottles. FDA found yeast, mold and Achromobacter bacteria in the products, which are not sterile. No injuries have been reported.
SeriousFDAJan 14, 2026Medinatura2 products
- SpecGx oxycodone-acetaminophen tablets recalled for possible missing imprint
SpecGx LLC is recalling certain bottles of oxycodone and acetaminophen 10mg/325mg tablets because some tablets may be missing the imprint (marking). This could make it difficult to identify the medication. No injuries have been reported.
ModerateFDAJan 14, 2026SpecGx2 products
- ORL Kids bubblegum mouthwash, toothpaste recalled for manufacturing quality issues
ORL Labs is recalling two ORL Kids bubblegum-flavored products: a 16.9 oz mouthwash and a 4 oz natural toothpaste. The products were not made under the required current good manufacturing practices, which are the quality standards for making drugs. The recall covers products distributed only in Arizona, and no injuries have been reported.
ModerateFDAJan 14, 2026Signature Formulations2 products
- Imprimis Dexamethasone-Moxifloxacin and Tri-Moxi+ recalled for glass particles
Imprimis is recalling three prefilled eye injection products because they may contain glass-like particles. The products are Dexamethasone Moxifloxacin, Dexamethasone Moxifloxacin Ketorolac, and Tri-Moxi+, with 1,688 affected boxes shipped nationwide. No injuries have been reported.
ModerateFDAJan 14, 2026Imprimis3 products
- Alembic fesoterodine tablets recalled for impurity level above limit
Alembic Pharmaceuticals is recalling one lot of Fesoterodine Fumarate 8 mg extended-release tablets because testing found levels of a chemical impurity (diester impurity) that exceed safety limits. The affected lot is 2405003360, which expires January 31, 2026.
ModerateFDAJan 14, 2026Alembic Pharmaceuticals
- Check your trazodone tablets for dents
Zydus Pharmaceuticals is recalling certain bottles of trazodone 100mg tablets because some tablets have dents on the surface. The defect affects lot EA00237A with an expiration date of 04/30/2027. No injuries have been reported.
FDAJan 7, 2026Zydus
- Glenmark ondansetron tablets recalled for unsealed blister packs
Glenmark Pharmaceuticals discovered that blister packs containing Ondansetron 4mg orally disintegrating tablets are not fully sealed, allowing tablets to fall out. The affected product was repackaged and distributed nationwide. This applies to lot #19251311 with an expiration date of April 2027.
ModerateFDAJan 7, 2026Glenmark
- Wegovy injection recalled for particulate matter
Novo Nordisk discovered hair in some prefilled Wegovy injection pens. This affects specific lot numbers manufactured in Denmark. No injuries have been reported.
ModerateFDAJan 7, 2026Novo Nordisk2 products
- Stop using BD ChloraPrep Triple Swabsticks
CareFusion 213, LLC is recalling BD ChloraPrep Triple Swabsticks (a skin antiseptic swab) because the manufacturer cannot confirm the product was properly sterilized. The affected lot (#5086623, expiring 3/31/2028) was distributed nationwide. No injuries have been reported.
ModerateFDAJan 7, 2026CareFusion
- Merck Emend and Noxafil Powdermix recalled for metal particulates
Merck is recalling two prescription medicines, Emend (aprepitant) for oral suspension 125 mg single-dose kits and Noxafil Powdermix (posaconazole) 300 mg packets, because they may contain metal particles. The recall covers 3 Emend kits and 845 Noxafil Powdermix kits, distributed nationwide. No injuries have been reported.
ModerateFDADec 31, 2025Merck2 products
- Sun Pharma/Taro ciclopirox shampoo recalled for impurity test failures
Taro Pharmaceuticals is recalling specific lots of Ciclopirox Shampoo 1% because the product failed quality tests for impurities and degradation at the 18-month mark. The affected lots expire January 31, 2026. No injuries have been reported.
ModerateFDADec 24, 2025Sun Pharmaceutical
- Preferred Pharmaceuticals ondansetron ODT recalled for unsealed blisters
Preferred Pharmaceuticals is recalling ondansetron ODT 4mg tablets because the blister pack containers are not fully sealed, which can cause tablets to fall out. The manufacturer Glenmark Pharmaceuticals notified Preferred Pharmaceuticals of the sealing defect. This affects specific lot numbers distributed nationwide.
ModerateFDADec 24, 2025Preferred Pharmaceuticals
- Somerset cisatracurium injection recalled for low potency
Somerset Therapeutics is recalling three cisatracurium besylate injection products because testing found the drug may be weaker than its label states. The recall covers 10 mg/5 mL, 200 mg/20 mL and 20 mg/10 mL vials, all made by Somerset Therapeutics in India and distributed nationwide. No injuries have been reported.
ModerateFDADec 24, 2025Somerset Therapeutics3 products
- Golden State Medical Supply baclofen recalled for foreign tablets
Golden State Medical Supply's baclofen 10 mg tablets in 1,000-count bottles (Lot GS065762) may contain foreign tablets or capsules mixed in. This affects 2,472 bottles distributed nationwide. No injuries have been reported.
ModerateFDADec 24, 2025Golden State Medical Supply
- Xylocaine, Polocaine and more dental anesthetic recalled for cracked cartridges
Novocol is recalling 7 dental anesthetic products because some cartridges may be cracked or broken. The products are sold under names including Xylocaine Dental, Polocaine Dental, Carbocaine, and OraVerse, plus private-label versions from Dentsply, Patterson Dental, darby dental supply, Benco Dental, and Cook-Waite. No injuries have been reported.
ModerateFDADec 24, 2025Novocol7 products
- Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
Defective container - seal not adhering to bottles
FDADec 17, 2025Lupin
- Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
FDADec 17, 2025Cipla3 products
- Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01
Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
FDADec 17, 2025Winder Laboratories
- Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Cross Contamination with Other Products
FDADec 17, 2025Glenmark
- Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
Incorrect Product Formulation
FDADec 17, 2025Fagron
- Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
FDADec 17, 2025Lupin
- Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
FDADec 17, 2025Dr. Reddy's
- Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.
Failed stability specifications: Out of specification for hardness test
FDADec 17, 2025Cipla2 products
- Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
FDADec 10, 2025Breckenridge2 products